9 Healthcare Tech Startups To Watch - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IoT
IoT
Healthcare // Leadership
News
12/29/2014
07:06 AM
Alison Diana
Alison Diana
Slideshows
Connect Directly
Twitter
LinkedIn
RSS
E-Mail

9 Healthcare Tech Startups To Watch

As venture capital flows into healthcare startups, look at some new companies that should be on your radar.
2 of 11

CliniOps
Founded in October 2013, CliniOps of Fremont, Calif., leverages social media, mobile, analytics, and cloud to transform clinical trials, Avik Pal, founder and CEO, explained in an interview. Pal, who was shocked at the manual, time-consuming processes involved in traditional clinical trials, also recognized the challenges associated with gathering information in emerging markets that lack broadband Internet access, widespread computer literacy, and knowledge. 
'Since about 20% of Phase 3 clinical trials are done outside of the US to ensure a heterogeneous mix of subject populations, an efficient design of a software with a focus to work in those conditions is absolutely needed -- [and that is] what I bring to the table: a strong background in technology with on-the-ground experience and understanding of how technology innovation can work in those conditions.' 
CliniOps software also includes checks and balances to ensure companies maintain compliance and ethical standards, he added, especially in regions known for unethical practices. The startup won several awards last year and was a finalist in the North Bay Innovation Summit, IBM SmartCamp 2014, and EPPICon 2014. 

(Image: CliniOps)

CliniOps
Founded in October 2013, CliniOps of Fremont, Calif., leverages social media, mobile, analytics, and cloud to transform clinical trials, Avik Pal, founder and CEO, explained in an interview. Pal, who was shocked at the manual, time-consuming processes involved in traditional clinical trials, also recognized the challenges associated with gathering information in emerging markets that lack broadband Internet access, widespread computer literacy, and knowledge.

"Since about 20% of Phase 3 clinical trials are done outside of the US to ensure a heterogeneous mix of subject populations, an efficient design of a software with a focus to work in those conditions is absolutely needed -- [and that is] what I bring to the table: a strong background in technology with on-the-ground experience and understanding of how technology innovation can work in those conditions."

CliniOps software also includes checks and balances to ensure companies maintain compliance and ethical standards, he added, especially in regions known for unethical practices. The startup won several awards last year and was a finalist in the North Bay Innovation Summit, IBM SmartCamp 2014, and EPPICon 2014.

(Image: CliniOps)

2 of 11
Comment  | 
Print  | 
Comments
Newest First  |  Oldest First  |  Threaded View
Bahati Pop
50%
50%
Bahati Pop,
User Rank: Apprentice
12/10/2016 | 12:04:26 PM
Inquiry
This is a great post. Now thinking about it, I need to buy health insurance for 2017. I live in Miami, Sunny Isles to be more precise. Has anyone worked with alltrustfl.com? Thank you
SumiA899
50%
50%
SumiA899,
User Rank: Apprentice
1/20/2015 | 8:17:05 PM
health start ups cliche'd and misses point
So like the big pharma fallacy, the PR trolls will cite epic misinformation violating the AMA Code of Ethics to make sure the masses are completely misguided so they can stay sick to need these things.  So many of these "Cures" and the big hype on Obamacare is a big disaster in the first place.  It's HORRIBLE.  

I was exploited for $4000 and I caught the doctors red handed.  No tech, no drug would've spared me the trouble caused by a severe conflict of interest.  I am ready to pull their hair out.  

Some of these "start ups" are gimmicks.  I get the entire Blue Sky business where nepotism is encouraged for the right reasons, but in todays' market- nothing gets IPO'd unless it's already big.  So they're just getting their friends to buy them out.  

And we, taxpayers who helped fund the tech expansion for the techies only at our expense as consumers of a monopolized sector stuck in red tape are supposed to go along with innovation to benefit as an economy, consumer or healthcare provider.  So somebody with investors' money in a big firm can buy them out and make their friends rich.  

 
anon3609451783
50%
50%
anon3609451783,
User Rank: Apprentice
1/6/2015 | 10:56:20 AM
End To End Solution
There are e2e solutions getting developed which will be more useful. Like device to collect data, analysis, automated personal recommendation and delivery of medcines. This is specfically useful for chronic diseases. I know a company called Cooey Technologies doing this out of India. Not sure it will be available in US from them for now. But a company to watch.
impactnow
50%
50%
impactnow,
User Rank: Author
12/31/2014 | 1:01:52 AM
To our health!

It's a great list. I think the potential is tremendous for technology to attack contagious diseases and help those with chronic illnesses reduce crises. These companies all have interesting solutions that touch on these areas, I hope they are successful in their efforts for all our health! The challenge will be integrating all this technology into the existing infrastructures to become most effective and efficient.

asksqn
50%
50%
asksqn,
User Rank: Ninja
12/29/2014 | 4:33:39 PM
I smell another bubble
With all the money being poured into healthcare startups that VCs, no doubt, consider easy money to be made, this is remniscent of the late 90s/early 2000s when the tech boom was in full swing.  Unfortunately, the dot com days soon turned into dot bomb once the big players made their money.  However, everyone else was left holding a pink slip and/or left with an empty bank account.  I don't see a meaningful difference between then vs now.  It's the same irrational exuberance all over again.
Samir Qamar MD
100%
0%
Samir Qamar MD,
User Rank: Apprentice
12/29/2014 | 2:11:15 PM
MedWand
Thank you for recognizing MedWand. Our device is designed to move the entire telemedicine industry from consultations to actual, real-time examinations. In response to the point made in the article, we will absolutely be seeking the appropriate FDA clearances, a process that has already begun.

Samir Qamar

President, MedWand Solutions, Inc.
David F. Carr
50%
50%
David F. Carr,
User Rank: Author
12/29/2014 | 2:10:55 PM
Simple is good
The smart pill bottle strikes me as the most focused and useful of the products in this batch.
kstaron
50%
50%
kstaron,
User Rank: Ninja
12/29/2014 | 11:57:29 AM
Neuro start up entrepenuers
In the Neuro startup challenge I would be interested to know how STEM researchers faired against entrepenuers in the later stages. Since getting venture capital depends on getting your message across so people want to spends on it, I'm wondering if the entrepenuers stastically beat out the STEM researchers for getting into the later rounds of the start up. Either way it looks like a steallar way for new healthcare ideas to get funded.
Slideshows
10 Cyberattacks on the Rise During the Pandemic
Cynthia Harvey, Freelance Journalist, InformationWeek,  6/24/2020
News
IT Trade Shows Go Virtual: Your 2020 List of Events
Jessica Davis, Senior Editor, Enterprise Apps,  5/29/2020
Commentary
Study: Cloud Migration Gaining Momentum
John Edwards, Technology Journalist & Author,  6/22/2020
White Papers
Register for InformationWeek Newsletters
Video
Current Issue
Key to Cloud Success: The Right Management
This IT Trend highlights some of the steps IT teams can take to keep their cloud environments running in a safe, efficient manner.
Slideshows
Flash Poll